Highlights
- Cipla shares gained nearly 4% during Monday's trading session.
- The stock touched an intraday high of Rs 1,404.90 amid active trading.
- Consolidated net profit stood at Rs 542.51 crore in Q4 FY26.
Cipla Limited (NSE:CIPLA) shares traded higher on June 22, 2026, with the stock rising 3.74% to Rs 1,402.70. The pharmaceutical company gained Rs 50.90 from its previous close of Rs 1,351.80. The stock opened at Rs 1,372.00 and moved higher during the session, touching an intraday high of Rs 1,404.90. The day's low stood at Rs 1,370.60.
Trading activity remained active, with 13.84 lakh shares changing hands and traded value reaching Rs 192.53 crore. The volume-weighted average price (VWAP) was Rs 1,391.43.
Financial Performance
Source: Company Filing
Valuation And Market Position
Cipla commands a market capitalisation of Rs 1.13 lakh crore, while its free-float market capitalisation stands at Rs 78,655.32 crore. The stock is currently trading at a price-to-earnings ratio of 28.22, with an adjusted P/E ratio of 26.66.
Cipla is a constituent of the Nifty 50 index and operates within the pharmaceuticals industry. The company has been listed on Indian stock exchanges since February 8, 1995.
Return Trends Across Timeframes
Cipla's stock performance has varied across investment horizons. Over the past week, the stock gained 1.52%, compared with a 1.27% rise in the Nifty 50. Over one month, the stock delivered a return of 0.22%, trailing the benchmark's 1.85% gain.
On a year-to-date basis, Cipla declined 6.57%, while the Nifty 50 fell 7.61%. The stock has generated a return of 40.47% over three years and 46.71% over five years.
Trading Range And Volatility Indicators
Cipla's 52-week high stands at Rs 1,673.00, recorded on October 23, 2025, while its 52-week low is Rs 1,165.70, touched on April 2, 2026. The stock currently trades without a price band restriction.
Daily volatility is reported at 1.41%, while annualised volatility stands at 26.94%. The impact cost remains low at 0.02, indicating relatively liquid trading conditions.
Business Overview
Incorporated in 1935, Cipla Ltd is engaged in the manufacturing, development and marketing of a wide range of branded and generic formulations as well as active pharmaceutical ingredients (APIs). The company operates across multiple therapeutic categories and serves domestic and international markets.
Key Risks To Watch
- Regulatory observations can affect product approvals and operations.
- Pricing pressure in key markets may impact profitability.
- Currency fluctuations can influence overseas earnings.
- Competition from generic drug manufacturers may affect market share.
Today's Share Performance
Cipla shares were among the notable gainers on June 22, 2026, rising 3.74% to Rs 1,402.30 during morning trade. The stock touched an intraday high of Rs 1,404.90 after opening at Rs 1,372.00.
Trading volumes reached 13.84 lakh shares, with turnover of Rs 192.53 crore. At the current price, the stock is approximately 16.2% below its 52-week high of Rs 1,673.00 and about 20.3% above its 52-week low of Rs 1,165.70.
Source: TradingView
Summary
Cipla (NSE:CIPLA) shares climbed 3.74% on June 22, 2026, amid active trading activity. The pharmaceutical company reported consolidated total income of Rs 6,689.36 crore and net profit of Rs 542.51 crore for the quarter ended March 2026. While the stock remains below its 52-week high, it has delivered positive returns over longer-term periods and continues to be a constituent of the Nifty 50 index.
FAQs
Q: Why did Cipla shares rise on June 22, 2026?
A: Cipla shares gained 3.74% during the session amid active trading and increased investor interest.
Q: What was Cipla's consolidated net profit in Q4 FY26?
A: Cipla reported consolidated net profit of Rs 542.51 crore for the quarter ended March 2026.
Q: What is Cipla's current 52-week trading range?
A: Cipla's 52-week high is Rs 1,673.00 and its 52-week low is Rs 1,165.70.